Breast Cancer Meeting Highlights - Page 4 - HER2 Support Group Forums

		HER2 Support Group Forums
Breast Cancer Meeting Highlights

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Page 4 of 14

« First

Last »

Threads in Forum : Breast Cancer Meeting Highlights

Forum Tools

Search this Forum

Rating Thread / Thread Starter	Last Post	Replies	Views
BC patients w/1-3 positive nodes and low risk 70-gene profile have excellent survival Hopeful	12-17-2007 08:23 AM by Hopeful	0	1,428
Her2 Recurrence Rates pre-Herceptin Hopeful	12-16-2007 02:40 PM by Andrea Barnett Budin	9	2,804
Comparison of joint problems as reported by patients in a randomised adjuvant trial Hopeful	12-14-2007 02:43 PM by Hopeful	0	1,794
Impact of ERBB2 on prognosis and microarray data Hopeful	12-14-2007 02:45 PM by Hopeful	0	1,793
The clinical significance of polysomy 17 in the HER2+ N9831 intergroup adjuvant trast Hopeful	12-14-2007 02:48 PM by Hopeful	0	1,739
Mechanism of action of herceptin killing of HER-2+ breast cancer cells under in vitro Hopeful	12-14-2007 02:49 PM by Hopeful	0	1,800
AI's in early breast cancer toxicity and adherence Hopeful	12-14-2007 03:14 PM by Hopeful	0	2,126
Confirmatory Tissue Biopsy for BC mets strongly recommended Hopeful	12-17-2007 08:25 AM by Hopeful	0	1,354
Multidisciplinary management of menopause symptoms after breast cancer Hopeful	12-17-2007 08:27 AM by Hopeful	0	1,262
For R.B - Her2 and fatty acid synthase in bc cells Hopeful	12-17-2007 08:29 AM by Hopeful	0	1,428
San Antonio Abstracts on line Early Hopeful	12-02-2008 09:42 AM by Hopeful	0	1,268
Reduction of chemotherapy side effects with a calcium phosphate nanoparticle delivery Hopeful	12-04-2008 07:57 AM by Hopeful	0	1,471
Influence of zoledronic acid on disseminated tumor cells (DTC) in primary bc Hopeful	12-04-2008 07:51 AM by Hopeful	0	1,155
Clinical outcomes of patients with T1N0 breast cancers: how important are biological Hopeful	12-04-2008 07:54 AM by Hopeful	0	1,245
Estimating recurrences prevented from using trastuzumab in adjuvant bc in the USA Hopeful	12-04-2008 07:55 AM by Hopeful	0	1,321
MG28, a novel fatty acid synthase inhibitor, overcomes resistance to anti-HER therapy Hopeful	12-04-2008 07:58 AM by Hopeful	0	1,516
Neratinib (HKI-272), an irreversible pan erbB receptor tyrosine kinase inhibitor Hopeful	12-05-2008 08:03 AM by Hopeful	0	1,671
Lapatinib can activate or supress estrogen receptor (ER) signaling in cell models of Hopeful	12-05-2008 08:07 AM by Hopeful	0	1,666
Intermittent treatment of hormone-dependent breast cancer using exemestane Hopeful	12-05-2008 08:09 AM by Hopeful	0	1,539
Deletion of STAT5 prevents HER2/Neu/ErbB2-induced mammary tumor development Hopeful	12-05-2008 08:10 AM by Hopeful	0	1,576
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted Hopeful	12-05-2008 08:12 AM by Hopeful	0	1,613
electro-acupuncture for aromatase inhibitor related arthralgia in bc survivors Hopeful	12-08-2008 08:15 AM by Hopeful	0	1,548
Study on survival times for stage IV bc over 3 decades Hopeful	12-08-2008 08:16 AM by Hopeful	0	1,576
Hercetpin tx for recurrence free patients with persistent DTC in bone marrow Hopeful	12-08-2008 08:18 AM by Hopeful	0	1,634
Trastuzumab treatment in elderly patients with advanced breast cancer Hopeful	12-08-2008 08:19 AM by Hopeful	0	1,683
Trastuzumab 6 mg/kg and 4 mg/kg can be infused safely over 30 minutes Hopeful	12-08-2008 08:20 AM by Hopeful	0	1,717
HER2 positive early breast cancers: tumour demographics and trastuzumab therapy Hopeful	12-08-2008 08:21 AM by Hopeful	0	1,756
Tumor necrosis factor transactivates ErbB2 in breast cancer cells Hopeful	12-09-2008 07:54 AM by Hopeful	0	1,639
Complications of methylene blue dye infiltration for sentinel lymph node biopsy in bc Hopeful	12-10-2008 07:23 AM by Hopeful	0	1,905
Combination antiHER therapeutics efficacy of alternative dosing regimens in ER+/HER2 Hopeful	12-09-2008 07:31 AM by Hopeful	0	2,020
Evaluation of aromatase expression in mammographically dense and non-dense regions of Hopeful	12-09-2008 07:33 AM by Hopeful	0	1,870
Histologic markers of mammographic breast density: core-needle biopsy tissue from Hopeful	12-09-2008 07:34 AM by Hopeful	0	1,776
Reliable data on 5- and 10-year survival provides accurate estimates of 15-year survi Hopeful	12-09-2008 07:56 AM by Hopeful	0	1,807
RFA of lumpectomy cavities: technique to increase negative margins Hopeful	12-10-2008 07:21 AM by Hopeful	0	1,770
BCafter stopping estrogen plus progestin in postmenopausal women in the whi Hopeful	12-10-2008 07:28 AM by Hopeful	0	1,756
A novel breast tissue feature strongly associated with risk of breast cancer Hopeful	12-10-2008 07:30 AM by Hopeful	0	1,881
HER-2 expression on circulating tumor cells in metastatic breast cancer Hopeful	12-10-2008 07:31 AM by Hopeful	0	1,610
Behaviour and metastatic potential of Her2+ and Her2-(CETC) during adjuvant therapy Hopeful	12-10-2008 07:34 AM by Hopeful	0	1,526
Metastatic potential of Her2+ and Her2- CETC released during primary systemic chemo Hopeful	12-11-2008 07:36 AM by Hopeful	0	1,562
Abundance and distribution of polychlorinated biphenyls (PCBs) in breast tissue Hopeful	12-11-2008 07:37 AM by Hopeful	0	1,896
Is metabolic syndrome the link between obesity and postmenopausal breast cancer? Hopeful	12-11-2008 07:38 AM by Hopeful	0	1,670
Promoter hypermethylation is an early event in breast carcinogenesis Hopeful	12-11-2008 07:40 AM by Hopeful	0	1,608
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathologica Hopeful	12-11-2008 07:44 AM by Hopeful	0	1,488
Remarkable complete pathologic response rate in Her2+ stage II/III pts in phase II tr Hopeful	12-11-2008 07:47 AM by Hopeful	0	1,812
Discovery of a new phospho-HER2+/FISH- molecular subtype Hopeful	07-08-2009 12:24 PM by Rich66	1	964
Clinical relevance of small tumor size (pT1a-b) for patients with HER2+ node neg bc Hopeful	06-19-2009 06:24 AM by Hopeful	0	753
Does hormone receptor positivity affect prognosis in Her2+ bc? Hopeful	06-22-2009 06:23 AM by Hopeful	0	862
Pattern of relapse and risk of second malignancies in molecular subtypes of early bc Hopeful	06-22-2009 06:22 AM by Hopeful	0	839
Impact of molecular subtype on presenting characteristics of T1a,b tumors Hopeful	06-25-2009 06:38 AM by Hopeful	0	658
role of estrogen receptor β expression as a predictive and/or prognostic factor in bc Hopeful	06-26-2009 06:49 AM by Hopeful	0	1,168
Incomplete surgical resection of DCIS results in activation of HER-2 in residual bc Hopeful	06-26-2009 11:59 AM by Hopeful	2	1,257
Interactions of bc cells w/microenvironment of the human bone marrow Hopeful	06-26-2009 06:21 AM by Hopeful	0	914
Correlation of quantitative total HER2 expression and HER2 homodimers in FinHer study Hopeful	06-26-2009 06:51 AM by Hopeful	0	950
Impact of biopsy cavities in breast cancer samples on recurrence risk Hopeful	06-26-2009 06:52 AM by Hopeful	0	782
Relationship of BMI, meno status, HRT & BC risk Hopeful	10-09-2009 02:12 PM by Hopeful	0	880
The association between the use of statin and breast cancer recurrence Hopeful	10-09-2009 02:17 PM by Hopeful	0	705
BSGI compared to breast MRI Hopeful	10-09-2009 02:31 PM by Hopeful	0	825
MBC patients with very high Her2+ and herceptin resistance Hopeful	10-09-2009 02:35 PM by Hopeful	0	749
Biopsy cavities in bc specimens: Impact on gene expression profiles and recur. Score Hopeful	10-09-2009 02:41 PM by Hopeful	0	883
Does estrogen receptor expression vary with fixation time? Hopeful	10-09-2009 02:44 PM by Hopeful	0	978
Advocate involvement in NCCN Breast Cancer Guidelines: A model of advocate/researcher Hopeful	10-12-2009 06:37 AM by Hopeful	0	913
Comparison of perceptions in bc patients in acute & extended survival phases Hopeful	10-12-2009 06:55 AM by Hopeful	0	871
Pleomorphic Calcifications, Tumor Markers, and Response to Therapy Hopeful	12-15-2009 08:19 AM by Hopeful	0	872
The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Hopeful	12-15-2009 08:12 AM by Hopeful	0	772
Poor Survival Outcomes in Elderly HER2 Positive Breast Cancer Patients Hopeful	12-15-2009 08:04 AM by Hopeful	0	804
Distant Metastasis Free Survival in Breast Cancer Patients with Micrometastases Hopeful	12-14-2009 09:58 AM by Hopeful	0	676
Resident Macrophages Influence Stem Cell Activity in the Mammary Gland Hopeful	12-14-2009 09:50 AM by Hopeful	0	652
Behaviour of CETC during Adjuvant Trastuzumab Treatment in Patients with Her2+ BC Hopeful	12-16-2009 07:23 AM by Hopeful	0	814
Paclitaxel related neuropathy in pts who did not receive Herceptin = improved outcome Hopeful	12-16-2009 07:26 AM by Hopeful	0	920
Xtalk between ER Receptor alpha 36 & HER2 Promotes Tumor Cell Survival Hopeful	12-16-2009 07:29 AM by Hopeful	0	934
mTORC1 Activity Contributes to the Mcl-1 Dependence of HER2 Amplified BC Cells Hopeful	12-16-2009 07:31 AM by Hopeful	0	780
Does Primary Systemic Therapy Erradicate Disseminated and Circulating Tumor Cells? Hopeful	12-16-2009 07:33 AM by Hopeful	0	760
Amplification and Activation of HER2 in CTCs in MBC pts Hopeful	12-16-2009 07:39 AM by Hopeful	0	1,012
Bone Marrow Micrometastasis as Correlated to Other Prognostic Factors in BC Hopeful	12-16-2009 07:41 AM by Hopeful	0	854
Evaluation of CA 27.29 as Prognostic Marker in Primary Breast Cancer Patients Hopeful	12-16-2009 07:42 AM by Hopeful	0	1,042

Page 4 of 14

« First

Last »

	New posts		Hot thread with new posts
	No new posts		Hot thread with no new posts
	Thread is closed

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 09:10 PM.